Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G

Passive or exempt beneficial ownership filing.

Ownership

12%

Beneficial ownership of this reported class.

Shares

6,850,237 shares

Shares beneficially owned as disclosed.

Event date

23 Oct 2026

Date tied to the ownership event or amendment.

Accepted by SEC

30 Oct 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
57,565,017 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13G
Accepted by SEC
30 Oct 2026, 19:26:36 UTC
Event date
23 Oct 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Venrock Healthcare Capital Partners III, L.P. disclosed 12% ownership in Lycia Therapeutics, Inc. Common Stock, $0.0001 par value per share on 23 Oct 2026.

Key facts

  • Venrock Healthcare Capital Partners III, L.P. filed SCHEDULE 13G for Lycia Therapeutics, Inc. Common Stock, $0.0001 par value per share.
  • Disclosed ownership: 12%.
  • Date of event: 23 Oct 2026.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Oct 2026, 19:26.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (9)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Venrock Healthcare Capital Partners III, L.P. 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Co-Investment Holdings III, LLC 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Venrock Healthcare Capital Partners EG, L.P. 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Management III, LLC 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
VHCP Management EG, LLC 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
Venrock Healthcare Capital Partners XP, L.P. 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By VHCP Management XP, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Management XP, LLC 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
Bong Y. Koh 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact
Nimish Shah 12% 6,850,237 0 6,850,237 /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .